Bo Han

发表

Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI

J. Trevino, J. Rosenberg, Edward Agyare, 2020, Cancer Nanotechnology.

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma

N. Zhang, Gu He, Jin Zhou, 2019, Acta pharmaceutica Sinica. B.

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Thomas George, Edward Agyare, D. DeRemer, 2023, Journal of the National Medical Association.

Proliferative and apoptotic effects of andrographolide on the BGC‐823 human gastric cancer cell line

Jing Yang, L. Shu, Z. Ye, 2013, Chinese medical journal.

Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer

S. Krishnan, J. Trevino, Edward Agyare, 2020, Scientific Reports.

Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

Raviteja Bulusu, J. Trevino, Edward Agyare, 2023, BMC Cancer.

Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

Raviteja Bulusu, Edward Agyare, Xue-mei Zhu, 2022, BMC cancer.

Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer

Raviteja Bulusu, Edward Agyare, S. Rogers, 2023, International journal of molecular sciences.

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models

S. Krishnan, J. Trevino, Edward Agyare, 2020, International journal of pharmaceutics: X.